title: Medical Management of Patients Undergoing Dentoalveolar Surgery.
abstract: The oral and maxillofacial surgeon (OMS) should have an understanding of common medical comorbidities. This understanding allows for risk stratification and thus prevention of potential problems. Remaining knowledgeable regarding diseases, diagnosis, treatment strategies, and pharmacology ultimately improves patient care. This article provides an update on some of the most common medical diseases for the patient undergoing dentoalveolar surgery.
authors.affiliation: Division of Oral and Maxillofacial Surgery, Department of Surgery, Emory University, School of Medicine, 1365 Clifton Road, Northeast, Building B, Suite 2300, Atlanta, GA, USA. Electronic address: sabram5@emory.edu.
authors.forename: Shelly
authors.initials: S
authors.lastname: Abramowicz
authors.affiliation: Division of Oral and Maxillofacial Surgery, Department of Surgery, Emory University, School of Medicine, 1365 Clifton Road, Northeast, Building B, Suite 2300, Atlanta, GA, USA.
authors.forename: Steven M
authors.initials: SM
authors.lastname: Roser
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage; D059266:Bisphosphonate-Associated Osteonecrosis of the Jaw / Q000628:therapy; D015897:Comorbidity; D019468:Disease Management; D006801:Humans; D019647:Oral Surgical Procedures; D017410:Practice Guidelines as Topic; D018570:Risk Assessment
chemical_list: D000925:Anticoagulants
keywords: Anticoagulation; Dentoalveolar surgery; Medical management; Medication-related osteonecrosis